hotspot -WSS

hotspot

author：knowledge 2025-09-27 12:43:02 - browse：88

Human embryonic stem cells Annie Cavanagh/Wellcome Images

The Food and Drug Administration on Thursday unveiled a series of guidelines that aim to encourage the development of promising and legitimate stem cell therapies while distinguishing them from the largely untested stem cell treatments hawked by unregulated clinics around the country.

The FDA’s guidelines have been expected and eagerly awaited by the stem cell community given the rapid proliferation of untested — and potentially unsafe — therapies around the country. Clinics promoting these therapies claim to be able to treat ailments from autism to neurodegenerative disorders to erectile dysfunction.

The guidelines also spell out how the agency will implement the regenerative medicine provisions in a behemoth law enacted last year called the 21st Century Cures Act.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Why did Pfizer dish out millions for a Super Bowl ad?

WSS

The dental labor crisis is a moment of opportunity

BioAge raises $170M for combination therapy with Zepbound

Top private equity targets in 2023: cardiology, clinical trials, lasers

Biden report: The neurospychology of memory and aging

The Readout: Gilead, Bernie Sanders, and other pharma news

Unique patient identifier: Experts argue the benefits, pitfalls

knowledge

hotspot

leisure time

What does generative AI mean for health care? We asked experts

Why CTE doesn’t keep Americans from enjoying the Super Bowl

The cancer drug shortage isn’t new — and neither are the solutions

Top private equity targets in 2023: cardiology, clinical trials, lasers

Medicare details structure of new drug price negotiation program

340B reform proposal comes out of Senate working group

Alkermes shareholders re

Vaccine advisory panel ACIP left half staffed by HHS

Drug repurposing or repositioning? The language matters

KalVista pill reduced swelling 'attacks' caused by genetic disease

focus

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Why Novartis is going to walk from its acquisition of MorphoSys

340B reform proposal comes out of Senate working group

Global cancer cases to surge 77% by 2050, WHO report says

Problems with a popular proposal to regulate AI in health care

A protest over insulin prices is seen as a fight for life

hotspot

hotspot

explore

knowledge